首页> 美国卫生研究院文献>other >Depletion of Foxp3+ T Cells Abrogates Tolerance of Skin and Heart Allografts in Murine Mixed Chimeras Without the Loss of Mixed Chimerism
【2h】

Depletion of Foxp3+ T Cells Abrogates Tolerance of Skin and Heart Allografts in Murine Mixed Chimeras Without the Loss of Mixed Chimerism

机译:Foxp3 + T细胞的耗竭消除了小鼠混合嵌合体的皮肤和心脏同种异体移植耐受性而没有混合嵌合体的丧失

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The relative contribution of central and peripheral mechanisms to the generation and maintenance of allograft tolerance is of considerable interest. Here, we present new evidence that regulatory T cells (Foxp3+) maintain skin and heart allograft tolerance in mixed hematopoietic chimeric mice. Transient depletion of both donor- and recipient-derived Foxp3+ cells was necessary and sufficient to induce decisive rejection of long-accepted skin and heart allografts. In contrast, stable hematopoietic chimerism remained, and there was no detectable induction of donor-specific reactivity to hematopoietic cells. Foxp3+ cell depletion did not result in the rejection of skin grafts of only MHC-disparate donors (B6.C-H2d/bByJ), indicating that MHC antigens were not the target in the graft. We conclude that two different mechanisms of tolerance are present in mixed chimeras. Hematopoietic chimerism, resistant to Foxp3+ depletion, is probably due to deletional tolerance to MHC antigens, as supported by previous studies. In contrast, regulatory tolerance mechanisms involving Foxp3+ cells are required to control reactivity against non-MHC antigens not present on hematopoietic lineages.
机译:中心和外围机制对同种异体移植耐受性的产生和维持的相对贡献是相当令人感兴趣的。在这里,我们提供了新的证据,证明调节性T细胞(Foxp3 + )在混合造血嵌合小鼠中维持皮肤和心脏同种异体移植耐受性。供体和受体来源的Foxp3 + 细胞的短暂耗竭是必要的,并且足以诱导长期接受的皮肤和心脏同种异体移植的决定性排斥。相比之下,稳定的造血嵌合仍然存在,并且没有可检测到的供体特异性反应对造血细胞的诱导。 Foxp3 + 细胞耗竭并没有导致仅MHC不同的供体(B6.C-H2 d / bByJ)的皮肤移植排斥,这表明MHC抗原不是移植物中的目标。我们得出结论,混合嵌合体中存在两种不同的耐受机制。如先前的研究所支持的,对Foxp3 + 耗竭有抵抗力的造血嵌合体可能是由于对MHC抗原的缺失耐受。相反,需要涉及Foxp3 + 细胞的调节耐受机制来控制针对造血谱系中不存在的非MHC抗原的反应性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号